Acta Biochimica et Biophysica Sinica · 2018 · 28 citations · 35 references
MedicineMolecular BiologyOncologyMetastasisMolecular OncologyTumor ProgressionCancer Cell SignalingMetastatic Breast CancerMetastatic Signaling PathwaysMolecular Tumor ProfilingRna InterferenceSignal Transduction In CancerCancer Cell Proliferation InhibitionCell Proliferation IndicesMatrix Metalloproteinase 9 GeneticsMatrix Metalloproteinase Gene ExpressionMatrix Metalloproteinase ModulationMatrix Metalloproteinase ProcessingMetastatic Breast Cancer BiologyRna Interference Therapeutics
Breast cancer is one of the most common malignancies. It is necessary to identify new markers for predicting tumor progression and therapeutic molecular targets. It has been reported that CD147 is one of the most commonly expressed proteins in primary tumors and in metastatic cells. In this study, we investigated the role of CD147 in human breast cancer metastasis and invasion, and examined its underlying molecular mechanisms. Immunohistochemistry results revealed high expression of CD147 in human breast tumor tissues, which was positively correlated with the malignancy of breast cancer. MCF-7 cells were transfected with CD147 siRNA eukaryotic expression vector, which resulted in significant knockdown of CD147. We found that CD147 siRNA dramatically inhibited cell proliferation, metastasis, and invasion. Furthermore, our results demonstrated that CD147 siRNA inhibited the synthesis of matrix metalloproteinase 9 (MMP-9) but had no significant effect on matrix metalloproteinase 2 (MMP-2). In addition, CD147 siRNA significantly inhibited the production of vascular endothelial growth factor (VEGF). Taken together, these data indicate that CD147 promotes breast cancer cell proliferation, metastasis, and invasion by modulating MMP-9 and VEGF expression. Thus, CD147 may be used as an important indicator for the judgment of malignant behavior of breast cancer, and may be a potential novel target for breast cancer therapy.
35
Metastatic potential correlates with enzymatic degradation of basement membrane collagen
Lance A. Liotta, Karl Tryggvason, Spiridione Garbisa et al. · Nature · 1980 · 1.8K citations
Proteogenomics connects somatic mutations to signalling in breast cancer
Philipp Mertins, D.R. Mani, Kelly V. Ruggles et al. · Nature · 2016 · 1.8K citations · Full text
A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
Swarnali Acharyya, Thórdur Óskarsson, Sakari Vanharanta et al. · Cell · 2012 · 1.1K citations · Full text
Medicine, Cancer Biology, Oncology +10
Exosome Transfer from Stromal to Breast Cancer Cells Regulates Therapy Resistance Pathways
Mirjam C. Boelens, Tony J. Wu, Barzin Y. Nabet et al. · Cell · 2014 · 799 citations · Full text
Medicine, Cell Biology, Oncology +16
Progesterone receptor modulates ERα action in breast cancer
Hisham Mohammed, I. Alasdair Russell, Rory Stark et al. · Nature · 2015 · 668 citations